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Background: CaBP7 is an EF-hand containing 
transmembrane protein which inhibits PI4KIIIβ 
activity.  
Results: PI4KIIIβ interacts with CaBP7 NTD 
which exhibits an expansive hydrophobic 
pocket. 
Conclusion: The structure of CaBP7 NTD is 
similar to CaM NTD but has a more expansive 
hydrophobic pocket containing fewer 
methionine residues. 
Significance: Regulation of PI4P synthesis is 
essential for vesicle trafficking and secretory 
pathway function. 
 
SUMMARY  
CaBP7 is a member of the calmodulin (CaM) 
superfamily that harbours two high affinity 
EF-hand motifs and a C-terminal 
transmembrane domain. CaBP7 has been 
previously shown to interact with and 
modulate Phosphatidylinositol 4-kinase III- 
Beta (PI4KIIIβ) activity in in vitro assays and 
affects vesicle transport in neurons when 
overexpressed. Here we show that the N-
terminal domain (NTD) of CaBP7 is sufficient 
to mediate the interaction of CaBP7 with 
PI4KIIIβ. CaBP7 NTD encompasses the two 
high affinity Ca
2+
 binding sites and structural 
characterisation through multi-angle light 
scattering, circular dichroism and NMR 
reveals unique properties for this domain. 
CaBP7 NTD binds specifically to Ca
2+
 but not 
Mg
2+
, and undergoes significant 
conformational changes in both secondary 
and tertiary structure upon Ca
2+
 binding. The 
Ca
2+
-bound form of CaBP7 NTD is 
monomeric and exhibits an open 
conformation similar to that of CaM. Ca
2+
-
bound CaBP7 NTD has a solvent-exposed 
hydrophobic surface which is more expansive 
than observed in CaM or CaBP1. Within this 
hydrophobic pocket there is a significant 
reduction in the number of methionine 
residues that are conserved in CaM and 
CaBP1 and shown to be important for target 
recognition. In CaBP7 NTD these residues 
are replaced with isoleucine and leucine 
residues with branched side chains which are 
intrinsically more rigid than the flexible 
methionine side chain. We propose that these 
differences in surface hydrophobicity, charge 
and methionine content may be important in 
determining highly specific interactions of 
CaBP7 with target proteins such as PI4KIIIβ. 
----------------------------------------------------------- 
The Ca
2+
-binding proteins (CaBPs) are a 
subfamily of the calmodulin (CaM)-related 
superfamily of EF-hand containing calcium 
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sensors (1-5). The CaBP family are vertebrate 
specific and comprise seven proteins (CaBPs1-5 
and CaBP7 & 8) which have emerged as 
important regulators of ion channel function and 
intracellular trafficking enzymes (6,7). All 
members of the CaBP family have four EF-hand 
motifs with a similar domain organisation to 
CaM, however fundamental differences in EF-
hand activity and subcellular targeting 
mechanisms have led to a further subdivision 
within this family (1,8). CaBPs 1-5 have one 
inactive EF-hand motif (EF-2) which is unable 
to bind divalent cations and are either cytosolic 
or targeted to membranes via post-translational 
attachment of an N-linked myristoyl chain (2). 
CaBP7 and CaBP8 (also known as calneuron II 
and calneuron I, respectively), however, have 
only two active EF-hand motifs and possess a 
single transmembrane domain (TMD) close to 
their C-termini which allows them to associate 
with membranes of the trans-Golgi network 
(TGN) and intracellular vesicles (5,8-10). 
Evolutionary analysis of this family of calcium 
sensors suggests that CaBP7 and CaBP8 evolved 
independently of the rest of the CaBPs and 
represent a completely separate family of 
calcium sensors in their own right (1,6). 
CaBP7 and CaBP8 share a maximum of 
24% overall homology with other CaBP 
members but are 63% homologous to each other 
(1). Both proteins are highly evolutionarily 
conserved suggesting they might each perform 
important, non-redundant functions. The most 
highly conserved regions of CaBP7 and CaBP8 
encodes the two high affinity Ca
2+
 binding sites 
within the N-terminal half of the protein and the 
extreme C-terminus encoding the TMD. The 
extreme N-terminus and the connecting region 
between the EF-hands and the TMD are more 
variable.  
CaBPs 1-5 have been shown to interact 
with a number of target proteins common to 
those of CaM such as inositol trisphosphate 
receptors (11-14), L-type Ca
2+
 channels (15-21) 
and P/Q type Ca
2+
 channels (22-24). In contrast, 
only two CaBP7/8 interacting proteins have been 
described (10,25). A direct interaction between 
CaBP8 and TRC40 (transmembrane domain 
recognition complex 40) has been demonstrated 
using co-immunoprecipitation, proximity 
ligation assays and bioluminescence resonance 
energy transfer (10). TRC40 is important for the 
post-translational membrane insertion of tail-
anchored proteins such as CaBP7 and CaBP8 
and is therefore unlikely to be a target of 
physiological regulation by these proteins (9,10). 
Despite this, definitive proof that TRC40 is 
required for their membrane insertion has not yet 
been shown. 
A unique role for CaBP7 and CaBP8 in 
the regulation of PI4KIIIβ has been more 
thoroughly characterised using both binding 
assays and in vitro functional assays (25). 
CaBP7 and CaBP8 are thought to act in 
conjunction with the more distantly related 
calcium sensor, neuronal calcium sensor 1 
(NCS-1), which has been previously shown to 
promote PI4KIIIβ activity (25-29). Conversely, 
CaBP7 and CaBP8 act to inhibit 
phosphatidylinositol 4-phosphate (PI4P) 
production by PI4KIIIβ. The opposing 
physiological actions of CaBP7/8 and NCS-1 are 
suggested to provide a molecular switch 
regulating PI4KIIIβ function. At low Ca2+ levels, 
PI4KIIIβ is thought to preferentially bind to 
CaBP7 or CaBP8, placing a block on PI4KIIIβ 
activity whereas at elevated Ca
2+
 levels NCS-1 is 
able to compete with and displace CaBP7 and 
CaBP8. This in turn relieves kinase inhibition 
and direct binding of NCS-1 to PI4KIIIβ further 
augments PI4KIIIβ activity, increasing PI4P 
production and stimulating TGN to plasma 
membrane trafficking (25).  
In this study we show that the N-
terminal domain (NTD) but not the C-terminal 
domain (CTD) of CaBP7 is able to 
independently interact with PI4KIIIβ. The NTD 
is also the portion of CaBP7 which displays the 
highest degree of homology with other CaBP 
family members. Importantly, caldendrin, an 
isoform of CaBP1 with an extended N-terminus, 
has been shown to be unable to regulate 
PI4KIIIβ activity in vitro (25). It was therefore 
important to analyse the structure of CaBP7 
NTD to discover how differences between EF-
hand containing calcium sensors may determine 
their unique and non-redundant interactions. 
Through biophysical and NMR spectroscopy 
analyses, this study examines how the three-
dimensional structure of CaBP7 NTD compares 
to that of other similar EF-hand containing Ca
2+
 
sensors and what properties might determine the 
unique interaction of CaBP7 NTD with 
PI4KIIIβ. We show that the NTD of CaBP7 is 
monomeric, contains two functional EF-hand 
motifs which bind specifically to Ca
2+ 
and has an 
unstructured region at its extreme N-terminus. 
The overall structure is very similar to the C-
terminus of CaM, but displays different surface 
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properties and a unique unstructured N-terminal 
extension. 
 
EXPERIMENTAL PROCEDURES 
Protein expression and purification – CaBP7 
NTD (residues 1-100) and CaBP7 CTD 
(residues 88-188) were subcloned from a 
synthetic gene (Integrated DNA technologies, 
Leuven, Belgium) encoding human CaBP7 
(NP_872333.1) codon optimized for expression 
in Escherichia coli and inserted into the pE-
SUMOpro Kan vector (tebu-bio, Peterborough, 
UK). Expression of soluble His-SUMO-CaBP7 
NTD, His-SUMO-CaBP7 CTD or His-SUMO 
alone was induced in E. coli BL21 Star™ (DE3) 
(Invitrogen) using 1 mM isopropyl-1-thio-β-D-
galacto- pyranoside at 18°C for 16 hours. Cells 
were harvested by centrifugation and 
resuspended in lysis buffer containing 50 mM 
sodium phosphate pH 7.0, 300 mM NaCl plus 
protease inhibitors (Complete mini protease 
inhibitor cocktail tablets, Roche, Basel, 
Switzerland). After cell lysis by one shot cell 
disruption at 27 KPSI (Constant Sytems Ltd., 
Daventry, UK) soluble proteins were recovered 
by ultracentrifugation. The supernatant was 
applied to a charged HisTrap FF 5 ml affinity 
column, washed with 50 mM sodium phosphate 
buffer pH 7.0, 300 mM NaCl, 25 mM imidazole, 
and the recombinant protein eluted in 50 mM 
sodium phosphate pH 7.0, 300 mM NaCl with a 
linear imidazole gradient from 25 mM-500 mM. 
After buffer-exchange into 20 mM HEPES pH 
6.5, 150 mM NaCl, the eluted protein was 
cleaved with recombinant SUMO protease, 
reapplied to a metal affinity column to remove 
the cleaved His-SUMO tag, and the flow 
through containing CaBP7 NTD was collected. 
Based on SDS-PAGE analysis SUMO tag 
cleavage was 90-95% complete under these 
conditions. CaBP7 NTD was further purified by 
gel filtration on a Superdex 75 column (GE 
Healthcare). 
Uniformly isotope-labeled CaBP7 NTD 
was expressed in M9 minimal medium 
supplemented with 1 mM MgSO4, 50 μM CaCl2, 
23 mM NH4Cl, 22 mM glucose, 100 μl PTM1 
salts. Isotopically labeled 
15
NH4Cl and 
13
C-
glucose were the sole nitrogen and carbon 
sources, respectively. Single labeled 
15
N, but not 
double labeled protein preparations were 
supplemented with 0.5 g 
15
N-labelled ISOGRO® 
(ISOTEC®, Sigma) per 1 litre M9 minimal 
media. 
Apo CaBP7 NTD was prepared for 
NMR and CD analysis by addition of 5 mM 
EGTA and 5 mM EDTA to the sample followed 
by buffer exchange into 20 mM HEPES pH6.5, 
150 mM NaCl, 30 mM n-Octyl-β-D-
glucopyranoside using a PD-10 column. 
PI4KIIIβ pull down assay – Bovine 
brain cytosolic protein extracts were prepared 
from whole homogenised tissue (FirstLink, 
Birmingham, UK) as previously described (30). 
Briefly, after initial extraction into cytosol buffer 
(10 mM HEPES pH 7.8, 100 mM KCl, 2 mM 
MgCl2, 1 mM DTT) the cytosolic fraction was 
dialysed overnight against PI4KIIIβ binding 
buffer (20 mM HEPES pH 7.4, 100 mM KCl, 1 
mM DTT, 100 μM ATP, 100 μM MgCl2, 1 mM 
CaCl2). The dialysed extract was further clarified 
by centrifugation (15 000 x g 15 min, 4
o
C) prior 
to use. 
Recombinant His-SUMO, His-SUMO-
CaBP7 NTD and His-SUMO-CaBP7 CTD 
expression was induced as described above. 
After soluble protein had been recovered by 
ultracentrifugation, the supernatant was 
incubated with 2 ml loose metal affinity resin 
charged with cobalt (Talon™ resin, Takara Bio) 
equilibrated in lysis buffer to purifiy 
recombinant protein. After incubation for 1 hour 
at 4
o
C, the resin was washed with 40 volumes 
lysis buffer and equilibrated with 30 volumes 
PI4KIIIβ binding buffer. Each recombinant His-
SUMO fusion protein (5-10 mg) was then 
incubated with clarified bovine brain cytosol for 
2 hours at 4
o
C with constant agitation. After 
incubation with bovine brain cytosol, each 
column was washed with 40 volumes of 
PI4KIIIβ binding buffer. Specific Ca2+-
dependent binding proteins were eluted by 
incubation with 2 ml of the PI4KIIIβ binding 
buffer supplemented with 5 mM EGTA for 10 
mins at room temperature. An additional high-
salt elution step isolated all other binding 
partners using PI4KIIIβ binding buffer 
supplemented with 1 M NaCl. 
Eluted proteins were precipitated using 
the acetone/trichloroacetic acid (TCA) method. 
Briefly, 10 volumes cold 10 % TCA in acetone 
was added to each sample and incubated at 20
o
C 
overnight. Samples were then centrifuged (15 
000 x g, 10 min, 4
o
C) and the supernatant 
discarded. Each pellet was then washed in 5 
volumes cold acetone and incubated for 30 mins 
at 20
o
C before centrifugation (15 000 x g, 5 min, 
4
o
C). The supernatant was discarded and the 
pellets were resuspended in 100 μl SDS 
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dissociation buffer (125 mM HEPES pH 6.8, 
10% sucrose, 10% glycerol, 4% SDS, 1% β-
mercaptoethanol, 2 mM EDTA). Samples were 
boiled for 5 mins and analysed by SDS PAGE 
(NuPAGE® Novex™ 12% Bis-Tris Gels, 
Invitrogen).  
Western Blotting protocol – Protein 
samples were transferred from SDS-PAGE gels 
by transverse electrophoresis onto nitrocellulose 
membranes for detection by western blotting. 
Filters were probed with anti-PI4KIIIβ antibody 
(1:500, Merck Millipore). Immunoreactivity was 
detected after application of an anti-rabbit 
secondary antibody conjugated to horseradish 
peroxidase and visualized using ECL regents. 
The same loading volumes and dilutions were 
used for all eluates to allow comparability 
between His-SUMO fusion proteins.  
Native PAGE gel mobility shift assay – 
Protein samples (either control SUMO protein or 
CaBP7 NTD) were prepared in SDS-free loading 
buffer containing 50 mM Tris pH 7.5, 10% 
glycerol, 10% sucrose, 2 mM EDTA, 2 mM 
EGTA. To investigate Ca
2+
 and Mg
2+
 binding, 
either 10 mM CaCl2, 10 mM MgCl2 or 10 mM 
CaCl2 and 10 mM MgCl2 were added to the 
loading buffer. Protein samples were not boiled 
and were resolved on native PAGE gels 
containing 18 % acrylamide. Gels were stained 
with SimplyBlue™ SafeStain (Invitrogen). 
Circular Dichroism - A Jasco-J810 
spectropolarimeter was used for CD 
measurements in the far ultraviolet region (UV), 
from 190 to 260 nm. Spectra were recorded at 
protein concentrations of approximately 0.25 
mg/ml in a cuvette of 1 mm path length in a 
temperature-controlled cell holder at 25 °C. 
Spectra were monitored with a 0.2-nm step and 
10 averages. Samples were prepared in 20 mM 
HEPES pH 6.5, 150 mM NaCl, 30 mM n-Octyl-
β-D-glucopyranoside and all sample spectra 
were baseline corrected by subtraction of the 
spectra for buffer alone. 
Size Exclusion Chromatography-Multi 
Angle Laser Light Scattering (SEC-MALLS) 
analysis- CaBP7 NTD was run on a Superose 12 
10/300GL gel filtration column (GE Healthcare) 
equilibrated in 20 mM HEPES pH 6.5, 150 mM 
NaCl at 0.75 ml/min. Elution was monitored by 
a Wyatt EOS 18-angle laser photometer (Wyatt 
Technology, Santa Barbara, CA), an Optilab 
rEX refractive index detector and a Jasco UV-
2077 Plus UV/Vis spectrophotometer (Jasco, 
Easton, MD); these were coupled to a Quasi 
Elastic Light Scattering (QELS) detector for 
simultaneous measurement of hydrodynamic 
radius. Molar mass measurements were 
performed using both Astra 5.3.2.16 software 
(Wyatt Technology) and the “three detector 
method”. Values of mass and hydrodynamic 
radius are expressed as mean + standard error 
(SE). 
NMR spectroscopy – All NMR spectra 
were acquired at 303 K on Bruker AVANCE II+ 
600 MHz and 800 MHz spectrometers equipped 
with triple resonance cryoprobes. Samples for 
NMR were concentrated to 0.2-1 mM in 20 mM 
HEPES pH 6.5, 150 mM NaCl. To prevent 
protein aggregation 30 mM n-Octyl-β-D-
glucopyranoside was added. All samples were 
prepared in 90% H2O/10% D2O unless otherwise 
stated. Sequence-specific backbone resonance 
assignment was obtained using HNCACB, 
CBCA(CO)NH, HNCO and HN(CA)CO, triple-
resonance experiments. Side-chain assignment 
was obtained using a 3D HCCH-TOCSY 
experiment (10.8 ms mixing time). NOE’s were 
derived from 3D 
15
N- and 
13
C-edited NOESY-
HSQC experiments with 130 ms mixing times. 
One-bond 
1
H-
15
N residual dipolar couplings 
were obtained from 
1
H-
15
N IPAP-HSQC spectra 
collected in Pf1 bacteriophage (20 mg ml
-1
). The 
final values of the magnitude and rhombic 
components in the refinement stage were, 
respectively, 3.864 and 0.647. Hydrogen-bond 
restraints were derived from 
1
H-
15
N HSQC 
spectra in 100% D2O. All spectra were 
processed with Bruker Topspin and analysed 
using the CCPN Analysis package (31). 
15
N longitudinal and transverse 
relaxation rates were obtained on Bruker 
AVANCE II+ 800 MHz spectrometer using two-
dimensional 
1
H-
15
N correlation pulse sequences. 
The 
15
N R1 and R2 values at 800 MHz were 
obtained using 12 delays (20, 50, 200, 400, 800, 
1200, 1400, 1600, 1800 and 2000 ms for R1, 4.8, 
9.6, 19.2, 28.8, 48, 72, 96, 120, 144, and 168 ms 
for R2).  
Structure calculation and validation – 
Structures of CaBP7 NTD were calculated in a 
two stage process using the ARIA (32) and 
CYANA (33) packages. CYANA was used to 
generate lists based on automated NOE 
assignment. The generated restraint lists were 
then used as input for final structure calculation 
in ARIA, with the inclusion of DANGLE-
derived dihedral restraints (34), residual dipolar 
coupling, and distance restraints between Ca
2+
 
and residues in positions 1, 3, 5, 7, and 12 in the 
EF-hand loops (1 and 2). Nine iterations were 
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performed, generating 200 structures. After 
refinement the 20 lowest energy structures were 
selected and analysed. The final structures were 
assessed using PROCHECK-NMR (35) and 
validated by comparing the correlation between 
experimentally measured RDCs and back-
calculated RDCs from the final structure using 
the PALES program (36). The NMR-derived 
structure and NMR assignments of CaBP7 NTD 
was deposited in the Protein Data Bank (PDB 
code: 2LV7) and the Biological Magnetic 
Resonance Bank (BMRB code: 18557). 
 
RESULTS 
CaBP7 N-terminus but not C-terminus binds 
PI4KIIIβ in a Ca2+-dependent manner – 
Attempts to express and purify full length 
CaBP7 gave only a very low yield of soluble 
protein. The protein was found mainly in the 
insoluble fraction which could be explained by 
the presence of the highly hydrophobic C-
terminal TMD causing aggregation of the 
protein (10). The structure and function of 
related calcium sensors, CaBP1 and CaM, have 
often been studied by splitting these proteins 
into independent N- or C- terminal lobes (37-
41). A similar approach was adopted here in 
order to identify the region of CaBP7 which 
interacts with PI4KIIIβ. Affinity pull down 
assays were performed using either the N-
terminal domain (NTD, residues 1-100) or C-
terminal domain (CTD, residues 88-188) of 
CaBP7 (Fig. 1A). The C-terminal TMD, which 
would normally be buried within intracellular 
membranes, was excluded from these 
experiments. Affinity purification columns were 
prepared with either immobilised His-SUMO, 
His-SUMO-CaBP7 NTD or His-SUMO-CaBP7 
CTD (Fig. 1A and B). Each affinity column was 
incubated with bovine brain cytosol extract in 
the presence of Ca
2+
 to pull out specific binding 
partners. Ca
2+
-dependent interacting proteins 
were eluted using an EGTA wash followed by a 
high salt wash to elute any Ca
2+
-independent 
partners. Eluted samples were analysed by 
western blot by probing with a polyclonal 
PI4KIIIβ antibody. A PI4KIIIβ reactive protein 
of the correct molecular mass was found to bind 
specifically to CaBP7 NTD and not CaBP7 CTD 
or the His-SUMO tag alone (Fig. 1C). PI4KIIIβ 
was eluted with the EGTA wash indicating that 
this is a Ca
2+
-dependent interaction. 
CaBP7 NTD binds specifically to Ca
2+
 
and not Mg
2+
 - Many EF-hand containing 
proteins have been demonstrated to bind to and 
undergo both Mg
2+
- and Ca
2+
-induced 
conformational changes (38,42-44). Free Mg
2+
 
levels in the resting cell are estimated at between 
0.5 – 5 mM (45) and it is thought that for these 
proteins the conformation in the presence of 
Mg
2+
 is more physiologically relevant than the 
apo form. The specificity of Ca
2+
 binding to 
CaBP7 NTD was investigated using native 
PAGE to monitor the electrophoretic mobility of 
CaBP7 NTD in the presence or absence of Ca
2+
 
or Mg
2+
 (Fig. 2). The control protein, SUMO, 
exhibited no change in electrophoretic mobility 
under any of the conditions tested. An excess of 
Mg
2+
 failed to influence the migration of CaBP7 
NTD when compared to Ca
2+
-free/Mg
2+
-free 
conditions. An excess of Ca
2+
, however, induced 
a significant retardation in the migration rate of 
CaBP7 NTD which was unaffected by the 
presence of equimolar Mg
2+
. This significant 
Ca
2+
-dependent shift in electrophoretic mobility 
is consistent with specific binding of Ca
2+
 to 
CaBP7 NTD and is in agreement with 
previously published data demonstrating that full 
length CaBP7 does not bind Mg
2+
 (25). 
Ca
2+
-binding induces a change in the 
helical content of CaBP7 NTD – Circular 
dichroism analysis scanning between 190 nm 
and 260 nm demonstrated that both Ca
2+
-bound 
and apo-CaBP7 NTD adopt a high degree of 
helical content (Fig. 3). The Ca
2+
-bound form 
exhibited an increase in the negative value of 
ellipticity  (2-7 millidegrees) between 200 nm 
and 230 nm compared to the apo-form 
demonstrating a significant increase in helical 
content. This suggests that the protein undergoes 
Ca
2+
 induced alterations in secondary structure.  
Ca
2+
-bound CaBP7 NTD is monomeric 
–A previous study has reported that full length 
CaBP7 forms soluble dimers both in vitro and in 
vivo in a Ca
2+
 independent manner. To 
investigate whether Ca
2+
-bound CaBP7 NTD is 
monomeric or dimeric, SECMALLS and NMR 
analyses were performed. The theoretical 
molecular mass of CaBP7 NTD is 11.4 kD (Fig 
4A). SECMALLS analysis showed that CaBP7 
NTD has an apparent molecular mass of 11.1 (± 
0.1%) kDa (Fig. 4B), which is consistent with 
CaBP7 NTD existing in monomeric form under 
the conditions tested. In agreement with this, 
NMR spectroscopy also suggested that the 
protein was monomeric. The average rotational 
correlation time of CaBP7 NTD was calculated 
to be 7.34 ns, consistent with the apparent 
molecular mass calculated by SECMALLS.  
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Ca
2+
-binding induces changes in the 
tertiary structure of CaBP7 NTD - NMR 
spectroscopy was used to probe Ca
2+
-dependent 
conformational changes to CaBP7 NTD tertiary 
structure. The peaks in the 
1
H-
15
N HSQC NMR 
spectra represent main chain and side chain 
amide groups, providing a residue-specific 
fingerprint of the protein conformation. After 
purification the protein was found to be in the 
Ca
2+
-bound form without the addition of external 
Ca
2+
. This could be discerned by the presence of 
two downfield shifted peaks (
1
H 10.5 ppm and 
10.2 ppm) which are characteristic of conserved 
glycine residues at the 6-position of divalent ion-
occupied EF-hands (Fig. 5A). Treatment of the 
sample with divalent metal ion chelators, EGTA 
and EDTA, to generate apo-CaBP7 NTD caused 
a dramatic change in the 
1
H-
15
N HSQC spectrum 
(Fig 5B). Notably, the two characteristic 
downfield shifted peaks at 
1
H 10.5 ppm and 10.2 
ppm were no longer visible. The HSQC 
spectrum for apo-CaBP7 NTD exhibited good 
peak dispersion with well-resolved non-
overlapping peaks suggesting the protein is 
folded in the absence of Ca
2+
. 107 peaks rather 
than the expected 92 backbone amide peaks (100 
less the 7 prolines and the N-terminus 
methionine residue) were observed, however, 
and a mixture of peak intensities were also 
apparent. The NMR data therefore suggests the 
presence of some conformational heterogeneity 
under the conditions used. 
Under solution NMR conditions, 
addition of Mg
2+
 to CaBP7 NTD induced protein 
precipitation, a documented effect of non-
specific binding of divalent cations to proteins 
with a net negative charge (46-49). Addition of 
Ca
2+
 to apo-CaBP7 NTD did not have the same 
effect and a shift was seen from the apo-form to 
the Ca
2+
-bound holo form. Significant chemical 
shift dispersion (
1
H 5.8 ppm to 10.6 ppm) and 
uniform peak intensities were observed in the 
1
H-
15
N HSQC spectrum for Ca
2+
-bound CaBP7 
NTD suggesting that the protein was stably 
folded (Fig. 5A). In this spectrum, 99 peaks 
were observed compared to the expected 92, 
again suggesting a small degree of 
conformational heterogeneity. Using sequential 
connectivities from standard triple resonance 
spectra 86.0% of the CaBP7 NTD backbone and 
79.4% of the amino acid side chains were 
assigned (Fig. 5B). The first 13 amino acids 
from the N-terminus exhibited weak NMR 
signals that could not be assigned. The two 
downfield shifted peaks at 
1
H 10.5 and 10.2 ppm 
were assigned to the glycines at the 6-position of 
each of the two EF-hands (Gly-51 and Gly-87) 
as expected and consistent with Ca
2+
 bound at 
both EF-1 and EF-2. Other dispersed peaks 
unique to the Ca
2+
-bound spectrum include Ile-
53, Lys-55, Ser-54, Met-83, Val-89, Asp-90 and 
the side-chain amides of Gln-88. Along with 
Gly-51 and Gly-87, these residues also reside 
within the Ca
2+
 binding loops of the two EF-
hands. The spectra of the apo and Ca
2+
 bound 
protein were too dissimilar to enable transfer of 
any backbone assignments between the two. 
NMR-derived structure of Ca
2+
-bound 
CaBP7 NTD – On the basis of the NMR-
assignments, the structure of CaBP7 NTD was 
calculated using 1965 inter-proton distance 
restraints obtained from 
1
H-
15
N and 
1
H-
13
C 
NOESY-HSQC spectra, 37 RDC restraints 
measured in Pf1 bacteriophage, 165 DANGLE-
derived backbone torsion angles and 32 
hydrogen-bonds (Table 1). The twenty 
calculated structures with the lowest total free 
energy have a backbone RMSD of 0.43 Å for the 
structured regions (Table 1). The final calculated 
structures were validated using PROCHECK 
NMR which shows that 81.1% of the residues 
belong to the most favourable region of the 
Ramachandran plot. The correlation between the 
measured and back-calculated RDC’s to the 
lowest energy structure in the ensemble shows a 
good fit between the two values, with a R 
correlation value of 0.996. For additional 
validation, the structure of CaBP7 NTD was 
calculated with the 37 experimentally-derived 
RDC restraints removed, and the lowest energy 
structure was used to calculate the correlation 
between measured and back-calculated RDC’s. 
In this case, the R correlation value was 0.899, 
showing a close correlation between the final 
structure and experimentally-derived RDC 
values. 
The final NMR-derived structure of 
Ca
2+
-bound CaBP7 NTD is illustrated in Figure 
6. The structure contains four α-helices and two 
β-strands: α1 (residues 32-45), α2 (residues 55-
65), α3 (residues 72-81), α4 (residues 91-98), β1 
(residues 53-54), β2 (residues 89-90). CaBP7 
NTD contains two EF-hand domains: EF1 (Fig. 
6, yellow, residues 32-65) and EF2 (Fig. 6, blue, 
residues 72-100) with a linker domain joining 
the two. The first 30 amino acids are 
unstructured. 
 The geometry of covalent bonds 
chelating Ca
2+
 in each of the two EF-hands was 
modelled using structural constraints derived 
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from the X-ray crystal structure of Ca
2+
 bound 
CaM, which has been shown to closely resemble 
the binding site geometry conserved in other EF-
hand proteins (50). This approach has been 
previously used to model the Ca
2+
 binding 
geometry of CaBP1 (37). 
Comparison of Ca
2+
-bound CaBP7 NTD 
to Ca
2+
-bound CaM and CaBP1 – Comparison 
of the structure of CaBP7 NTD with the 
established structures of related EF-hand 
containing calcium sensors is important to 
further the understanding of how calcium 
sensors with similar sequence and structure are 
able to regulate distinct protein targets. 
Bioinformatic analyses have previously shown 
that CaBP7 exhibits a low degree of homology 
to CaM and other members of the CaBP family 
(1). The structure of CaM has been extensively 
studied both through X-ray crystallography and 
NMR analysis (50,51). More recently, solution 
NMR and X-ray structures of CaBP1 have been 
solved (37,39,52) and it has been shown to 
closely resemble CaM in both its domain 
structure and its ability to regulate similar 
targets. Importantly, both proteins have been 
shown to possess two independent domains, the 
first encompassing EF-1 and EF-2 and the 
second, EF-3 and EF-4.  
 Figure 7A shows a multiple sequence 
alignment of CaBP7 NTD with the N- and C-
terminal domains of CaM and CaBP1. CaBP8 
NTD is also included for comparison. CaBP7 
NTD has a similar level of sequence identity 
with both N- and C- lobes of CaM and CaBP1 
when the non-homologous N-termini and linker 
regions are excluded from alignments (Table 2). 
Comparison of the known structures of these 
proteins show that the CTD of both CaM and 
CaBP1 are the most structurally homologous to 
CaBP7 NTD, with RMSD values of 1.35 and 
2.12, respectively. Figure 7B and C shows the 
NMR structure of CaBP7 NTD superposed with 
either CaM CTD or CaBP1 CTD, respectively. 
This figure illustrates the high degree of 
similarity in the overall tertiary structure of these 
Ca
2+
-sensing proteins. Table 3 shows the 
interhelical angles calculated between the helices 
of each EF-hand in Ca
2+
-bound CaBP7 NTD, 
and Ca
2+
-bound or unbound CaM and CaBP1 
(calculated using Helixang from the CCP4 suite 
of programs (53)). The interhelical angles for 
EF1 and EF2 in CaBP7 NTD are 116° and 87°, 
respectively, and reflect the Ca
2+
-bound open 
conformation that is typical of CaM-related 
Ca
2+
-sensors.  
Surface properties of Ca
2+
-bound 
CaBP7 NTD compared to Ca
2+
-bound CaM and 
CaBP1 CTDs - Space filling representations of 
Ca
2+
-bound CaBP7 NTD, CaM CTD and CaBP1 
CTD are illustrated in Figure 8. The back face of 
Ca
2+
-bound CaBP7 NTD displays few obvious 
deviations from the surface properties of CaM 
and CaBP1 CTDs. The most notable difference 
is a non-conserved basic residue (Lys-55) which 
replaces an uncharged amino acid in CaM and 
CaBP1.  
Analysis of the per residue solvent 
accessibility of CaBP7 NTD, CaBP1 CTD and 
CaM CTD (PDBePISA, pdbe.org/pisa (54)) 
revealed that the proportion of hydrophobic 
residues which contribute to the accessible 
surface area were 31.6%, 28.6% and 18.8%, 
respectively. In agreement with these values, 
CaBP7 NTD exhibits a striking solvent exposed 
hydrophobic surface (Front face, shown in 
orange and yellow, Fig. 8a) that is more 
expansive than seen in either CaM or CaBP1. 
Notably, within this hydrophobic region, non-
conserved hydrophobic residues can be observed 
in the interlinking loop between EF-1 and EF-2 
(Met-68) and in the first helix of EF-2 (Val-72 
and Val-76) which are either polar or uncharged 
at the corresponding positions in CaM and 
CaBP1. This results in a distinctive loss of 
charged residues surrounding the hydrophobic 
pocket; in CaM and CaBP1 these charges 
residues are thought to confer specific 
electrostatic contacts with target interacting 
proteins (37). In addition an acidic residue which 
is conserved in CaM and CaBP1 is replaced by a 
positively charged residue (Arg-80) in CaBP7.  
 Another notable difference between the 
three structures is the lack of methionine 
residues within the hydrophobic pocket of 
CaBP7 NTD. Methionine residues are shown in 
orange in figure 8 and can be observed outlining 
the hydrophobic pocket in CaM and CaBP1. 
There are four methionine residues in the CaM 
CTD which are also conserved within the CaM 
NTD (Fig 7A). These residues have been shown 
to be of particular importance for determining 
interactions with target binding proteins (55). 
Three of these methionine residues are 
conserved in CaBP1 CTD, however only one is 
conserved in CaBP7 (Met-62). Ile-77, Leu-97 
and Leu-98 in CaBP7 replace methionine 
residues at the equivalent positions in CaM (Fig. 
7A). Additional non-conserved methionine 
residues, Met-68 and Met-83 are found outside 
of the hydrophobic pocket of CaBP7 (Fig. 8A). 
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DISCUSSION 
This study describes the interaction of CaBP7 
NTD with PI4KIIIβ and the subsequent 
determination of the NMR solution structure of 
Ca
2+
-bound CaBP7 NTD. In vitro binding data 
show that the CaBP7 NTD, encompassing its 
two active EF-hands, is able to bind to PI4KIIIβ 
from bovine brain cytosol whereas CaBP7 CTD 
does not. PI4KIIIβ was found in the EGTA 
elution fraction for CaBP7 NTD only, 
suggesting that this is a Ca
2+
 dependent 
interaction. Full length CaBP7 and CaBP8 have 
been previously demonstrated to interact with 
and inhibit PI4KIIIβ (25). Contradictory to the 
results presented here, this interaction was 
reported to be Ca
2+
 independent in in vitro 
assays. The differences in the Ca
2+
-dependence 
observed in these two studies is likely due to 
differences in assay conditions, however in 
agreement with our findings Mikhaylova et al. 
reported that regulation of PI4KIIIβ by CaBP8 
was Ca
2+
-dependent as inhibition was 
augmented by an elevation in Ca
2+
 levels in in 
vitro kinase assays (25). 
CaBP7 and CaBP8 act in an opposing 
fashion to NCS-1 in the regulation of PI4KIIIβ 
activity. Despite both the CaBP and NCS 
families of proteins belonging to the CaM 
superfamily of EF-hand calcium sensors, they 
are known to possess numerous features which 
distinguish them from one another. Sequence 
analysis shows that these families are only 
distantly related with less that 20% homology 
between members of the two families. This is 
reflected in structural studies showing that 
members of the NCS family typically possess a 
globular structure with their four EF-hands 
arranged in a tandem array (56-62). In contrast, 
the structure of CaBP1 has been shown to more 
closely resemble the characteristic dumbbell-like 
conformation of CaM, which possesses two 
independent domains that are able to 
differentially regulate target binding proteins 
(37,39,52). 
The structure of NCS-1 homologs from 
Schizosaccharomyces pombe (Ncs1) (63) and 
Saccharomyces cerevisiae (frequenin) (64) in 
complex with an interacting peptide from the 
yeast PI4KIIIβ homolog, Pik1, have been 
previously studied and have provided important 
insights into how NCS-1 may regulate PI4KIIIβ 
activity. In both systems the Pik1 peptide forms 
two helices separated by a 20 residue linking 
loop. Upon Ca
2+
 binding to NCS-1 a 
hydrophobic pocket is exposed allowing binding 
of the two Pik1 helices in an antiparallel manner. 
This forces the peptide into a U-turn 
conformation and it is suggested that this could 
promote structural interactions between the lipid 
kinase unique (LKU) and catalytic domains of 
Pik1 leading to optimal activation of lipid kinase 
activity (63,64).  
Regulation of PI4KIIIβ by NCS-1 is an 
evolutionarily conserved mechanism and null 
mutations, which lack the NCS-1 orthologue, 
frequenin, or the PI4KIIIβ orthologue, Pik1, are 
lethal in yeast (65). Despite this, changes in 
NCS-1 regulation of PI4KIIIβ can be observed 
in higher organisms. The localisation of NCS-1 
in mammalian cells is not restricted to Golgi 
membranes as it is in yeast (28) and it has been 
found that the interaction of NCS-1 with 
PI4KIIIβ is of lower affinity than the interaction 
between yeast frequenin and Pik1 (66). 
Throughout evolution there has been a 
significant expansion in the number of EF-hand 
containing Ca
2+
 sensors both in the neuronal 
calcium sensor family and in other vertebrate-
specific families such as the CaBPs (1,67). This 
has led to increased complexity in the regulation 
of many processes including ion channel 
function and intracellular trafficking. This may 
have led to alterations in the mechanisms 
underlying the modulation of PI4KIIIβ activity 
and the discovery of an interaction of CaBP7 
and CaBP8 with PI4KIIIβ supports this theory.  
CaBP7 and CaBP8 form a separate sub-
family within the CaBP family due to their 
unique pattern of EF-hand activity and their 
ability to target to cellular membranes via a C-
terminal transmembrane domain (1,8-10). 
Unlike other members of the CaBP family which 
have three active EF-hand motifs and a 
redundant second EF-hand, CaBP7 and CaBP8 
possess only two active EF-hands which are 
both located in their N-terminal domain (6). Due 
to numerous amino acid deletions and 
substitutions there is little sequence conservation 
within their C-terminal EF hand motifs. These 
differences are likely to be fundamental for 
determining distinct, non-overlapping target 
interactors for these proteins compared to the 
other CaBP proteins.  
A previous study has reported a 
propensity of full length CaBP7 and CaBP8 to 
dimerise in a Ca
2+
 independent manner both in 
vitro and in vivo (10). Hradsky et al. suggested 
that CaBP7 and CaBP8 may have two 
dimerization interfaces: the hydrophobic TMD 
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and the cytosolic domain (10). Here we show 
through SECMALLS and NMR analyses that 
Ca
2+
-bound CaBP7 NTD is homogeneously 
folded and monomeric in nature under the 
conditions tested. This suggests that the 
previously reported dimerization interface most 
likely require residues present CaBP7 CTD.  
In agreement with previous studies we 
show that CaBP7 NTD binds specifically to Ca
2+
 
and not Mg
2+ 
(25). Whereas addition of Mg
2+
 to 
the protein resulted in precipitation, addition of 
Ca
2+
 resulted in a significant conformational 
change as evidenced by comparison of 
1
H-
15
N 
HSQC NMR spectra of apo and Ca
2+
-bound 
CaBP7 NTD. EF-hand domains in CaM-related 
calcium sensors typically adopt an open 
conformation upon binding to Ca
2+
 which 
exposes a highly hydrophobic pocket that can 
interact with target binding proteins. The 
calculated interhelical angles within the Ca
2+
-
bound NMR structure of CaBP7 NTD were in 
agreement with the protein adopting a similar 
open conformation and far-UV CD analysis 
revealed an increase in helical content upon Ca
2+
 
binding similar to that observed in CaM in 
previous studies (68). For NMR analyses we 
could only obtain high quality spectra in the 
presence of n-Octyl-β-D-glucopyranoside. 
Previous structural studies of small Ca
2+
 binding 
proteins have also employed this detergent 
(58,61,69). Significantly, our analyses show that 
Ca
2+
-bound CaBP7 NTD adopts a structural 
conformation which is very similar to that of 
CaM and CaBP1 CTDs. Based on this high 
degree of tertiary similarity, we believe that the 
presence of octylglucoside has not significantly 
distorted or influenced the CaBP7 NTD 
structure. This conclusion is validated by 
comparison of CaBP7 NTD 
1
H-
15
N HSQC 
spectra in the absence and presence of 30mM 
octylglucoside (Supplemental figure 1). No 
significant alterations were observed in key EF-
hand residue chemical shifts (the same that 
undergo extensive changes between apo- and 
Ca
2+
-bound forms of CaBP7 NTD), although 
peak intensity and the number of visible peaks 
both increased in the presence of octylglucoside. 
Collectively these data indicate that 30mM 
octylglucoside did not alter the tertiary structure 
of CaBP7-NTD. CaBP7-NTD, CaM CTD and 
CaBP1 CTD all contain four alpha helices and 
two beta sheets of similar length and 
arrangement. In particular the RMSD upon 
comparison of CaM and CaBP7 NTD was 1.36 
Å further demonstrating a tight correlation 
between the two structures.  
Despite the close similarities in the 
overall tertiary arrangement of the three proteins, 
analysis of their surface properties revealed 
more significant differences. CaBP7 NTD 
displays a more expansive hydrophobic pocket 
when compared to CaBP1 and CaM. 
Hydrophobic residues were found in place of 
charged residues at the corresponding positions 
in CaBP1 and CaM resulting in the loss of an 
electrostatic patch. Interestingly, in CaM and 
CaBP1 the hydrophobic pocket forms the 
binding surface for target proteins. Charged 
residues may be important for determining the 
specificity of interactions and the change in 
electrostatic potential may be significant for 
defining the ability of CaBP7 to regulate unique 
target proteins. Interestingly, comparison of the 
structured portion of CaBP7 NTD with CaBP8 
NTD revealed 81% sequence identity and 95.6% 
sequence similarity between the two proteins 
with only conservative amino acid changes 
within the hydrophobic pocket. Modelling of the 
CaBP8 NTD structure based on the structured 
region of Ca
2+
-bound CaBP7 NTD suggest that 
the structures of the two proteins are likely very 
similar (Fig. 9) and this may explain their ability 
to interact with and regulate the same target 
protein, PI4KIIIβ.  
The difference in the distribution of 
methionine residues on the surface of CaBP7 
NTD is also conserved in CaBP8. CaM 
possesses 9 methionine residues which 
contribute approximately 46% of the surface 
hydrophobicity in the N- and C- terminal 
domains (70). This high proportion of 
methionine residues is suggested to be the main 
reason that CaM is capable of binding such a 
diverse array of target proteins (70). The 
alignment in figure 7A demonstrates that there 
are four methionines in each of the N- and C-
terminal EF-hand pairs of CaM which reside at 
corresponding positions within the two 
sequences. CaBP1 CTD has methionines 
conserved at three of these positions but CaBP7 
and CaBP8 NTDs have only one. This supports 
previous bioinformatic analyses indicating that 
CaBP7 and CaBP8 evolved independently of 
other CaBPs (1,6). In place of the three 
methionine residues either Isoleucine (Ile 77) or 
Leucine (Leu-97 and 98) residues are found at 
these positions in CaBP7. Interestingly, 
conservative mutations of methionies to leucines 
in CaM, while not significantly altering the 
 Solution NMR structure of Ca
2+
-bound CaBP7 NTD  
 
 10 
overall structure of the protein, significantly 
alter CaMs ability to stimulate cAMP 
phosphodiesterase (PDE) (71). Furthermore, 
structural studies have demonstrated a vital role 
for these methionine residues in interactions 
with numerous CaM substrates (55,71). 
The importance of methionine residues 
for determining protein interaction interfaces can 
be explained by considering the enhanced 
flexibility of their side chains when compared to 
the more rigid branched side chains of isoleucine 
and leucine (70,71). Methionine side chains can 
adopt numerous configurations within proteins 
(72) meaning that a methionine-rich surface on a 
protein is potentially more malleable than a 
surface rich in isoleucine and leucine residues. 
The increased number of leucine and isoleucine 
residues in the exposed hydrophobic surface of 
CaBP7 NTD compared to CaM and CaBP1 may 
therefore make it less adaptable to binding 
partners of varying dimensions (71). This 
property may be important for conferring 
selectivity of binding to unique interactors such 
as PI4KIIIβ.  
The structural study presented here 
provides insights into how the structure of the 
EF-hand containing NTD of CaBP7 compares to 
other related calcium sensors and how 
differences may confer unique regulatory 
activities. We have shown that this domain is 
sufficient for binding to the only known 
physiological target of CaBP7, PI4KIIIβ, 
whereas the CTD is not. Difficulties expressing 
high levels of mammalian PI4KIIIβ have 
precluded structural characterisation of this 
protein and although binding peptides important 
for interactions with the yeast orthologue of 
NCS-1 have been identified in Pik1, there is 
little sequence homology between this peptide 
and mammalian PI4KIIIβ. Further structural 
analysis of mammalian PI4KIIIβ will therefore 
be required in order to deduce the exact nature of 
its interaction with CaBP7 and how this might 
confer an inhibitory action opposite to the 
effects of NCS-1.  
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TABLES 
 
Table 1. 
Structural statistics for the ensemble structures of CaBP7 NTD 
NOE restraints 1965 
Ambiguous 536 
Unambiguous 1429 
Intra (|i-j| = 0) 310 
Medium (0<|i-j|<5) 830 
Long (|i-j|≥5) 289 
Hydrogen bonds restraints 32 
Dihedral angle restraints (Φ, Ψ) 165 
Residual dipolar coupling restraints 37 
PALES validation of RDCs 
 R value 0.996 
Q-Value  0.091 
Root mean square deviation from ideal geometry   
Bond length (Å) 0.0015 ± 0.00009 
Bond angle (deg) 0.315 ± 0.008 
Root mean square deviation from average structure (Å)   
Secondary structure (backbone) 0.43 
Secondary structure (heavy) 0.92 
Ramachandran plot (%)   
Most favoured region 81.1 
Allowed region 18.1 
Disallowed region 0.8 
Average energy (kcal mol
-1
) 606.16 
 
 
Table 2. 
Percentage sequence identity and comparative RMSD values for Ca
2+
-bound CaBP1 (PDB codes: 
2LAN and 2LAP) and CaM (PDB code: 1CLL) compared to CaBP7 NTD (PDB code: 2LV7). 
Sequence identity was calculated based on alignment of CaBP7, CaBP1 and CaM excluding non-
homologous regions in the N-termini or linker regions of the proteins. The comparative RMSD was 
calculated using PDBeFold (pdbe.org/fold (73)). 
 
 % sequence identity RMSD (Å) 
CaM NTD 47.8 1.66 
CaM CTD 47.2 1.35 
CaBP1 NTD 47.8 3.54 
CaBP1 CTD 43 2.12 
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Table 3. 
Interhelical angles of the EF-hands in CaM, CaBP1 and CaBP7 NTD. The PDB codes were: apo-
CaM, 1CFD; Ca
2+
-bound CaM, 1CLL; Mg
2+
-bound CaBP1, 2K7B and 2K7C; Ca
2+
-bound CaBP1, 
2LAN and 2LAP; Ca
2+
-bound CaBP7 NTD, 2LV7. Angles were calculated using Helixang from the 
CCP4 suite of programs (53). 
 
 Interhelical angles (
o
) 
 
Helix pair 
Apo-CaM Ca
2+
-bound 
CaM 
Mg
2+
-bound 
CaBP1 
Ca
2+
-bound 
CaBP1 
Ca
2+
-bound 
CaBP7 NTD 
α1-α2 135 86 133 129 116 
α3-α4 134 94 139 138 87 
α5-α6 126 98 132 116  
α7-α8 136 90 123 87  
 
 
FIGURES LEGENDS 
 
FIGURE 1. Affinity pull down assay of PI4KIIIβ from bovine brain cytosol fraction using either the  
NTD or CTD of CaBP7 immobilised through a His6-tag on cobalt-charged metal affinity resin. (A) 
Schematic diagram of CaBP7. Blue boxes indicate active EF-hand domains. Red boxes indicate the 
C-terminal transmembrane domain (TMD). (B) Coomassie stained SDS-PAGE gel showing 
equivalent expression levels of SUMO, SUMO-CaBP7 NTD and SUMO-CaBP7 CTD used in pull 
down assays. (C) Western blot showing an immunoreactive band for PI4KIIIβ which is only extracted 
by SUMO-CaBP7 NTD and is eluted specifically by an EGTA wash. Bound proteins were eluted 
from resin using a 5 mM EGTA wash (first 3 lanes) followed by a 1M NaCl wash (last 3 lanes). 
 
FIGURE 2. Coomassie stained native PAGE gel showing the electrophoretic gel mobility of SUMO 
and CaBP7 NTD in the presence or absence of an excess of Ca
2+
 or Mg
2+
. Samples were resolved on 
an 18% acrylamide gel in loading buffer containing 2 mM EGTA and 2 mM EDTA with either 10 
mM CaCl2 or 10 mM MgCl2. The presence or absence of Ca
2+
 or Mg
2+ 
is indicated by + or – above 
each lane of the gel image. 
 
FIGURE 3. The effect of Ca
2+
 on far-UV CD of apo and Ca
2+
-bound CaBP7 NTD. Changes to 
CaBP7 NTD secondary structure were monitored by far-UV CD spectroscopy. The solid line 
represents the trace for apo-CaBP7 NTD and the dashed line represents the trace for Ca
2+
-bound 
CaBP7 NTD. To prepare apo CaBP7 NTD 5 mM EGTA and 5 mM EDTA were added to the sample 
then removed using a desalting column. Final samples were analysed in 20 mM HEPES pH 6.5, 150 
mM NaCl, 30 mM n-Octyl-β-D-glucopyranoside at 25oC. Each spectrum is representative of 10 
averaged scans and is normalized to the spectrum of buffer alone.  
 
FIGURE 4. CaBP7 NTD is monomeric. (A) Coomassie stained SDS-PAGE gel of CaBP7 NTD after 
purification and cleavage of His-SUMO-tag. The protein migrates at a rate consistent with the 
theoretical molecular mass of 11.4 kD (B) Size exclusion chromatography multi-angle laser light-
scattering (SECMALLS) characterization of Ca
2+
-bound CaBP7 NTD. The refractive index of the 
sample is plotted against elution volume. The molar mass distribution is indicated by the green line. 
The data illustrates that CaBP7 NTD forms a stable monomer in 20 mM HEPES pH 6.5, 150 mM 
NaCl at 20
o
C. There is a single peak with an average molar mass of 11.1 ±0.11 kD.  
 
FIGURE 5. 
1
H-
15
N HSQC spectra of CaBP7 NTD. (A) Assigned 
1
H-
15
N HSQC spectrum of Ca
2+
-
bound CaBP7 NTD and (B) 
 1
H-
15
N HSQC spectrum of apo CaBP7 NTD. Sample heterogeneity of 
apo CaBP7 NTD is seen from the unequal distribution of peak intensities. Asn and Gln side chain 
NH2 groups are indicated by peaks joined with a solid black line. Ca
2+
-bound CaBP7 NTD was 
prepared in 20 mM HEPES pH6.5, 150 mM NaCl, 30 mM n-Octyl-β-D-glucopyranoside. Apo CaBP7 
NTD was prepared by addition of 5 mM EGTA and 5 mM EDTA to the sample followed by buffer 
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exchange into 20 mM HEPES pH 6.5, 150 mM NaCl, 30 mM n-Octyl-β-D-glucopyranoside. Spectra 
were acquired at 303 K. 
 
FIGURE 6. Main chain structures of Ca
2+
-bound CaBP7 NTD determined by solution NMR (PDB 
code: 2LV7). (A) Superposition of the 20 lowest energy structures and (B) ribbon representation of 
the lowest energy structure seen from the front (left) and side (right). N-terminal residues (1-25) are 
unstructured and are not shown. EF-hand 1 is shown in yellow and EF-hand 2 is shown in blue. Red 
spheres represent bound Ca
2+
.  
 
FIGURE 7. Comparison of Ca
2+
-bound CaBP7 NTD, CaM CTD and CaBP1 CTD sequence and 
main chain structure. (A) Sequence alignment of CaBP7 NTD with CaBP8 NTD and the N- and C- 
terminal domains of CaM and CaBP1. Identical amino acids are highlighted in blue, similar amino 
acids are highlighted in red. Black boxes indicate the 12 amino acid Ca
2+
-binding loop of each EF-
hand. ‘*’ below the sequences indicate methionine residues which are conserved in CaM NTD and 
CTD. These are Met-36, -51, -71, and -72 in the N-terminal domain, and Met-110, -125, -145, -146 in 
the C-terminal domain. The NMR-derived secondary structure elements of CaBP7 NTD are indicated 
above the alignment. Cylinders indicate α-helices and arrows indicate β-sheets. (B and C) Ribbon 
representation of Ca
2+
-bound CaBP7 NTD (PDB code: 2LV7, residues 30-100) lowest energy 
conformer (purple) superposed with (B) Ca
2+
-bound CaBP1 CTD (cyan, PDB code: 2LAP) and (C) 
Ca
2+
-bound CaM CTD (yellow, PDB code 1CLL, residues 80-147). Red spheres represent bound 
Ca
2+
. 
 
FIGURE 8. Space-filling representations of (A) Ca
2+
-bound CaBP7 NTD (PDB code: 2LV7, residues 
30-100), (B) Ca
2+
-bound CaBP1 (PDB code: 2LAP) and (C) Ca
2+
-bound CaM (PDB code: 1CLL, 
residues 80-147). The front face is shown on the left and the back face is shown on the right. Acidic 
residues (Asp and Glu) and basic residues (Arg, His, Lys) are shown in red and blue, respectively. 
Hydrophobic residues (Ile, Leu, Phe, Trp, Val, Tyr) are shown in yellow with the exception of Met 
residues which are highlighted in orange.  
 
FIGURE 9. Space-filling representation of CaBP8 homology model. The front face is shown on the 
left and the back face is shown on the right. Acidic residues (Asp and Glu) and basic residues (Arg, 
His, Lys) are shown in red and blue, respectively. Hydrophobic residues (Ile, Leu, Phe, Trp, Val, Tyr) 
are shown in yellow with the exception of Met residues which are highlighted in orange. Solvent-
exposed amino acids which are significantly different from the corresponding residues in CaBP7 are 
labeled. The predicted surface of CaBP8 is very similar to CaBP7 (Fig. 8A). The homology model 
was predicted using the Modeller software package (74) and residues 30-100 of the calculated Ca
2+
-
bound CaBP7 NTD structure as a template .  
 
SUPPLEMENTAL FIGURE 1. Comparison of 
1
H-
15
N HSQC spectra obtained from Ca
2+
-bound 
CaBP7 NTD before (A) and after (B) addition of 30mM n-octyl- -D-glucopyranoside. Both spectra 
have dispersed peaks which are indicative of a folded protein. Addition of octylglucoside improved 
spectral peak intensity without causing significant movement in the positions of peaks. This allowed 
all residues from the structured part of CaBP7 NTD to be assigned. Peaks representing backbone 
amide groups from within the two EF-hands are labeled and circled red in A and B to highlight 
minimal changes in chemical shift values on octylglucoside addition. Asn and Gln side chain NH2 
groups are indicated by peaks joined with a solid black line. Ca
2+
-bound CaBP7 NTD was prepared in 
20 mM HEPES pH6.5, 150 mM NaCl. The concentration of protein in the sample was 130 μM. 
Spectra were acquired at 303 K. 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4.   
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Figure 5. 
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Figure 6. 
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Figure 7. 
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Figure 8. 
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Figure 9. 
 
 
 
